These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6798589)

  • 1. Effect of PGE1, PGE2 and PGI2 on ventricular arrhythmias during myocardial infarction in conscious dogs: relation to infarct size.
    Jugdutt BI
    Prostaglandins Med; 1981 Nov; 7(5):431-55. PubMed ID: 6798589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension.
    Jugdutt BI
    Circulation; 1983 Sep; 68(3):673-84. PubMed ID: 6409447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed effects of early infarct-limiting therapies on healing after myocardial infarction.
    Jugdutt BI
    Circulation; 1985 Oct; 72(4):907-14. PubMed ID: 3928195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of prostacyclin on coronary occlusion induced arrhythmia in cats.
    Dix RK; Kelliher GJ; Jurkiewicz N; Lawrence T
    Prostaglandins Med; 1979 Sep; 3(3):173-84. PubMed ID: 399533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins in myocardial: with emphasis on myocardial preservation.
    Jugdutt BI
    Prostaglandins Med; 1981 Aug; 7(2):109-23. PubMed ID: 7025070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney.
    Jackson EK; Heidemann HT; Branch RA; Gerkens JF
    Circ Res; 1982 Jul; 51(1):67-72. PubMed ID: 7044603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarction.
    Melin JA; Becker LC
    J Am Coll Cardiol; 1983 Aug; 2(2):279-86. PubMed ID: 6345632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of peripheral collateral arteries in the dog to prostaglandins E1, E2, F2 alpha, and I2 (prostacyclin).
    Williams PB; Joyner JH
    J Cardiovasc Pharmacol; 1982; 4(5):784-90. PubMed ID: 6182410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins and cyclic nucleotides: effects of PGI2 and PGE1 on cardiac hemodynamic and coronary arterial and myocardial cyclic nucleotide levels in dogs.
    Ito T; Ogawa K; Enomoto I; Hashimoto H; Kai I; Sakai K; Satake T
    Jpn Circ J; 1980 Sep; 44(9):755-61. PubMed ID: 6251292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination from the circulation of cats of 6-keto-prostaglandin E1 compared with prostaglandins E2 and I2.
    Förstermann U; Neufang B
    J Pharm Pharmacol; 1983 Nov; 35(11):724-8. PubMed ID: 6139453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation.
    Aiken JW; Gorman RR; Shebuski RJ
    Prostaglandins; 1979 Apr; 17(4):483-94. PubMed ID: 111306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nitroglycerin and ibuprofen on left ventricular topography and rupture threshold during healing after myocardial infarction in the dog.
    Jugdutt BI
    Can J Physiol Pharmacol; 1988 Apr; 66(4):385-95. PubMed ID: 3139268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nitroglycerin-methoxamine combination on infarct size in conscious dogs.
    Sheehan FH; Goldstein RE; Bolli R; Epstein SE
    Am Heart J; 1983 Jan; 105(1):37-43. PubMed ID: 6401371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin and regional coronary blood flow in experimental myocardial infarction.
    Herbaczynska-Cedro K; Karwatowska-Prokopczuk E; Michalowski J; Wennmalm A
    Clin Physiol; 1988 Jun; 8(3):255-66. PubMed ID: 3042272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1.
    Feld S; Li G; Wu A; Felli P; Amirian J; Vaughn WK; Gornet T; Swenson C; Smalling RW
    Am Heart J; 1996 Oct; 132(4):747-57. PubMed ID: 8831361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The actions of prostaglandins I2 and E2 on arrhythmias produced by coronary occlusion in the rat and dog.
    Au TL; Collins GA; Harvie CJ; Walker MJ
    Prostaglandins; 1979 Nov; 18(5):707-20. PubMed ID: 396577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive response to prostacyclin and 6-keto-PGE1 following hepatectomy in the rat.
    Van Dam J; Stinger RB; Penhos JC; Ramwell PW; Kot PA
    Proc Soc Exp Biol Med; 1984 Sep; 176(4):438-42. PubMed ID: 6379654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
    Fiedler VB; Mardin M
    Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
    Panzenbeck MJ; Hintze TH; Kaley G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):619-24. PubMed ID: 2831348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.